Physician profile
Leon E Brown
NPI 1568685246
$1,504.73
in general payments reported to CMS, 2019-2025
18 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $56.26 · 2021: $125 · 2022: $82.08 · 2023: $571 · 2024: $246 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618 · Travel and Lodging: $315 · Education: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.53 |
| Travel and Lodging | $315.00 |
| Education | $158.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $500.70 | 2019-2025 | Tremfya |
| Stryker Corporation | $315.00 | 2023 | Spy-Phi System |
| Pfizer INC. | $164.08 | 2020-2023 | |
| Abbvie INC. | $113.98 | 2021-2025 | Skyrizi |
| Lilly USA, LLC | $59.83 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Genzyme Corporation | $55.89 | 2022-2025 | |
| Galderma Laboratories, L.P. | $50.03 | 2019-2021 | |
| Arcutis Biotherapeutics, INC. | $49.28 | 2023-2024 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.98 | 2019-2023 | Arazlo, Jublia |
| Ucb, INC. | $23.92 | 2023 | Cimzia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.70 | 2024 | Spevigo |
| Mayne Pharma Commercial LLC | $22.76 | 2021 | |
| Almirall LLC | $21.54 | 2019 | |
| Incyte Corporation | $21.22 | 2025 | Opzelura |
| Amgen INC. | $18.15 | 2025 | Enbrel, Otezla |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $13.04 | 2021 | |
| Journey Medical Corporation | $6.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.